Federico Grossi - Mar 1, 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ David Watson, attorney-in-fact for Dr. Federico Grossi
Stock symbol
APLS
Transactions as of
Mar 1, 2022
Transactions value $
-$16,324
Form type
4
Date filed
3/2/2022, 05:15 PM
Previous filing
Feb 24, 2022
Next filing
Mar 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale -$16.3K -375 -0.34% $43.53 110K Mar 1, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a scheduled sale from 10B5-1 trading plan.